| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| BARD1 | BRCA1 | ENSPTRP00000075471 | ENSPTRP00000070120 | BRCA1 associated RING domain 1. | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | 0.999 |
| BARD1 | BRCA2 | ENSPTRP00000075471 | ENSPTRP00000009812 | BRCA1 associated RING domain 1. | Breast cancer 2, early onset. | 0.984 |
| BARD1 | BRIP1 | ENSPTRP00000075471 | ENSPTRP00000016108 | BRCA1 associated RING domain 1. | BRCA1 interacting protein C-terminal helicase 1. | 0.983 |
| BARD1 | CK820_G0052740 | ENSPTRP00000075471 | ENSPTRP00000032326 | BRCA1 associated RING domain 1. | PMS2 isoform 6. | 0.423 |
| BARD1 | MLH1 | ENSPTRP00000075471 | ENSPTRP00000025426 | BRCA1 associated RING domain 1. | MutL homolog 1, colon cancer, nonpolyposis type 2. | 0.701 |
| BARD1 | MRE11 | ENSPTRP00000075471 | ENSPTRP00000088458 | BRCA1 associated RING domain 1. | MRE11 isoform 6; Belongs to the MRE11/RAD32 family. | 0.983 |
| BARD1 | NBN | ENSPTRP00000075471 | ENSPTRP00000053119 | BRCA1 associated RING domain 1. | Nibrin; Component of the MRE11-RAD50-NBN (MRN complex) which plays a critical role in the cellular response to DNA damage and the maintenance of chromosome integrity. The complex is involved in double- strand break (DSB) repair, DNA recombination, maintenance of telomere integrity, cell cycle checkpoint control and meiosis. | 0.981 |
| BARD1 | PALB2 | ENSPTRP00000075471 | ENSPTRP00000013473 | BRCA1 associated RING domain 1. | Partner and localizer of BRCA2. | 0.921 |
| BARD1 | PMS2 | ENSPTRP00000075471 | ENSPTRP00000090549 | BRCA1 associated RING domain 1. | PMS1 homolog 2, mismatch repair system component. | 0.423 |
| BARD1 | TOPBP1 | ENSPTRP00000075471 | ENSPTRP00000026557 | BRCA1 associated RING domain 1. | Topoisomerase (DNA) II binding protein 1. | 0.990 |
| BRCA1 | BARD1 | ENSPTRP00000070120 | ENSPTRP00000075471 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | BRCA1 associated RING domain 1. | 0.999 |
| BRCA1 | BRCA2 | ENSPTRP00000070120 | ENSPTRP00000009812 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | Breast cancer 2, early onset. | 0.999 |
| BRCA1 | BRIP1 | ENSPTRP00000070120 | ENSPTRP00000016108 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | BRCA1 interacting protein C-terminal helicase 1. | 0.997 |
| BRCA1 | CK820_G0052740 | ENSPTRP00000070120 | ENSPTRP00000032326 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | PMS2 isoform 6. | 0.446 |
| BRCA1 | MLH1 | ENSPTRP00000070120 | ENSPTRP00000025426 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | MutL homolog 1, colon cancer, nonpolyposis type 2. | 0.974 |
| BRCA1 | MRE11 | ENSPTRP00000070120 | ENSPTRP00000088458 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | MRE11 isoform 6; Belongs to the MRE11/RAD32 family. | 0.978 |
| BRCA1 | NBN | ENSPTRP00000070120 | ENSPTRP00000053119 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | Nibrin; Component of the MRE11-RAD50-NBN (MRN complex) which plays a critical role in the cellular response to DNA damage and the maintenance of chromosome integrity. The complex is involved in double- strand break (DSB) repair, DNA recombination, maintenance of telomere integrity, cell cycle checkpoint control and meiosis. | 0.980 |
| BRCA1 | PALB2 | ENSPTRP00000070120 | ENSPTRP00000013473 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | Partner and localizer of BRCA2. | 0.999 |
| BRCA1 | PMS2 | ENSPTRP00000070120 | ENSPTRP00000090549 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | PMS1 homolog 2, mismatch repair system component. | 0.446 |
| BRCA1 | TOPBP1 | ENSPTRP00000070120 | ENSPTRP00000026557 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | Topoisomerase (DNA) II binding protein 1. | 0.987 |
